{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-006275","form_type":"8-K","ticker":"UFPT","cik":"0000914156","company_name":"UFP TECHNOLOGIES INC","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.370727+00:00","generated_at":"2026-05-30T02:35:36.925774+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"UFP Technologies Q3 net income up 40% to $16.4M, sales up 44% to $145.2M","bullets":["Net income rose 40% to $16.4M vs $11.7M YoY; adjusted net income up 46.5% to $18.6M.","Sales increased 44% to $145.2M; organic sales growth of 9.7% driven by robotic surgery and infection prevention markets.","Acquisitions accretive to EPS by ~$0.17 after absorbing $3.1M in interest expense; gross margin 28.6% despite $1.1M in purchase accounting costs.","Adjusted EBITDA up 61.4% to $31.2M; nine-month adjusted EBITDA $75.9M up 26% YoY.","Medical market sales up 52.2% to $132.6M; aerospace and defense up 27.9% year-to-date."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-006275","json":"https://secwatch.observer/filing/0001171843-24-006275.json","markdown":"https://secwatch.observer/filing/0001171843-24-006275.md","text":"https://secwatch.observer/filing/0001171843-24-006275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914156/000117184324006275/0001171843-24-006275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914156/000117184324006275/f8k_111224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:35:36.925774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}